Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added related topics Melanoma and MedlinePlus Genetics to the study page. The revision tag was updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T21:46:31.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; Melanoma and related topics (including MedlinePlus Genetics) and Revision: v3.4.2 have been removed.
    Difference
    0.2%
    Check dated 2026-03-11T18:16:42.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Deleted the related topics entries 'Melanoma' and 'MedlinePlus Genetics'. This update alters the related topics listing but does not affect the study content or eligibility information.
    Difference
    0.2%
    Check dated 2026-02-25T10:36:32.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and MedlinePlus Genetics; updated page revision to v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-11T05:20:10.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a government funding lapse notice about site operations and shows a revision update to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:12:12.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Added a glossary toggle; the page now shows Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed older items such as Melanoma, MedlinePlus Genetics, and the older Last Update/Revision entries (v3.3.4) from related topics and metadata.
    Difference
    0.4%
    Check dated 2026-01-28T03:47:44.000Z thumbnail image

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.